AG
TENX icon

Advisor Group’s Tenax Therapeutics TENX Stock Holding History

Advisor Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Hold
2
– – ﹤0.01% 4777
2019
Q3 		$4K Hold
2
– – ﹤0.01% 4779
2019
Q2 		$4K Sell
2
-2
-50% -$4.84K ﹤0.01% 4787
2019
Q1 		$13K Buy
+4
New +$9.12K ﹤0.01% 4229
2018
Q4 		– Hold
0
– – – 5229
2018
Q3 		– Hold
0
– – – 5213
2018
Q2 		– Hold
0
– – – 5044
2018
Q1 		– Hold
0
– – – 5062
2017
Q4 		– Hold
0
– – – 4858
2017
Q3 		– Hold
0
– – – 4938
2017
Q2 		– Hold
0
– – – 4675
2017
Q1 		– Hold
0
– – – 4581
2016
Q4 		– Hold
0
– – – 4139
2016
Q3 		– Hold
0
– – – 4086
2016
Q2 		– Hold
0
– – – 4002

Other funds holding TENX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Advisor Group's TENX Position: Q4 2019 in Review

Advisor Group held its Tenax Therapeutics (TENX) position steady in Q4 2019 at 2 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4777.

Advisor Group first reported a position in TENX in Q1 2019 and has held it in 4 quarters since. The position peaked at $13K in Q1 2019. 10 funds tracked by Wall St. Rank hold TENX as of Q4 2019.

  • Advisor Group held 2 shares of Tenax Therapeutics worth $4K as of Q4 2019.
  • Advisor Group left its Tenax Therapeutics share count unchanged in Q4 2019.
  • Tenax Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4777 holding.
  • Advisor Group first reported a position in Tenax Therapeutics in Q1 2019 and has held it in 4 quarters since.
  • Advisor Group's Tenax Therapeutics position peaked at $13K in Q1 2019.
  • 10 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.